Comments
Loading...

Corbus Pharmaceuticals

CRBPNASDAQ
Logo brought to you by Benzinga Data
$49.33
-1.57-3.08%
At Close: -
$49.33
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$88.00
Lowest Price Target1
$46.00
Consensus Price Target1
$76.20

Corbus Pharmaceuticals (NASDAQ:CRBP) Stock, Analyst Ratings, Price Targets, Forecasts

Corbus Pharmaceuticals Holdings Inc has a consensus price target of $76.2 based on the ratings of 5 analysts. The high is $88 issued by Oppenheimer on August 7, 2024. The low is $46 issued by Jefferies on March 6, 2024. The 3 most-recent analyst ratings were released by RBC Capital, RBC Capital, and Oppenheimer on August 28, 2024, August 7, 2024, and August 7, 2024, respectively. With an average price target of $84 between RBC Capital, RBC Capital, and Oppenheimer, there's an implied 70.28% upside for Corbus Pharmaceuticals Holdings Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
May
2
Jun
1
Jul
3
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Oppenheimer
HC Wainwright & Co.
B. Riley Securities
Jefferies

1calculated from analyst ratings

Analyst Ratings for Corbus Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Corbus Pharmaceuticals (CRBP) stock?

A

The latest price target for Corbus Pharmaceuticals (NASDAQ:CRBP) was reported by RBC Capital on August 28, 2024. The analyst firm set a price target for $82.00 expecting CRBP to rise to within 12 months (a possible 66.23% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Corbus Pharmaceuticals (CRBP)?

A

The latest analyst rating for Corbus Pharmaceuticals (NASDAQ:CRBP) was provided by RBC Capital, and Corbus Pharmaceuticals reiterated their outperform rating.

Q

When was the last upgrade for Corbus Pharmaceuticals (CRBP)?

A

The last upgrade for Corbus Pharmaceuticals Holdings Inc happened on March 6, 2024 when Jefferies raised their price target to $46. Jefferies previously had a hold for Corbus Pharmaceuticals Holdings Inc.

Q

When was the last downgrade for Corbus Pharmaceuticals (CRBP)?

A

There is no last downgrade for Corbus Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Corbus Pharmaceuticals (CRBP)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Corbus Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Corbus Pharmaceuticals was filed on August 28, 2024 so you should expect the next rating to be made available sometime around August 28, 2025.

Q

Is the Analyst Rating Corbus Pharmaceuticals (CRBP) correct?

A

While ratings are subjective and will change, the latest Corbus Pharmaceuticals (CRBP) rating was a reiterated with a price target of $82.00 to $82.00. The current price Corbus Pharmaceuticals (CRBP) is trading at is $49.33, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch